Stay Updated On The Latest News & Insights

Explore FemTech’s $1T potential, industry shifts, key innovations, and future trends shaping women’s health.

June is Pride Month, an annual observance dedicated to celebrating and advocating for the rights and inclusion of the LGBTQIA+ community. It is...

Despite decades of advancement in medical research, disparities in women’s health continue to impact patient outcomes and quality of life. The White...

In today's fast-paced world, where information overload is the norm, the need for evidence-based decision-making has never been greater. Systematic...

PBMs and GPOs are currently facing FTC inquiries into their business practices that impact drug pricing and access. This post reviews the nuances...

Vaccines have long been one of the most powerful tools in medicine, providing critical protection against infectious diseases and saving millions of lives worldwide....

Empowered patients, better outcomes —

We are PFG MedComm, a market access and medical communication strategic consultancy. The medical industry is filled with complex ideas that can be...

Last Saturday, August 26, 2023, was Women's Equality Day, which commemorates the day in 1920 when women were finally granted the right to vote after...

The recent approval of Narcan as an over-the-counter drug is a landmark decision that has the potential to save thousands of lives and highlights the...

Last week, we discussed Pride Month from the perspective of health equity in the LGBTQIA+ community. In our first Guest Blog post by Haylin Dennison,...

Beyond reviewing and approving drugs, the FDA plays a pivotal role in overseeing and approving medical devices, a realm defined by its innovation,...

For years, the standard method of payment to physicians has been “fee-for-service” (FFS). This method was introduced in the 1930s and refers to...

Let's face it, the healthcare landscape is complex - developing clear and concise value communication across stakeholders is essential.

Inflation affects nearly all goods and services on the market, including drugs and healthcare products. This is the first of a series of posts...

The journey from the research lab to a patient’s bedside for a drug is long, costly, and risky. Manufacturers make significant investments over many...

Rapid advances in therapeutic innovation are opening new possibilities across cancer, genetic disorders, and autoimmune disease.

As the focus on health equity grows, grassroots initiatives are helping bridge gaps in access, quality, and outcomes across diverse communities.

Behind every rare disease is a common challenge—limited treatments, high costs, and barriers to access that continue to shape patient outcomes.

As regulators raise the bar on clinical trial diversity, sponsors face new expectations to better reflect the populations most affected by disease.

A clear look at Medicare, Medicare Advantage, and the coverage trade-offs shaping access and affordability for millions of Americans.

Rising drug costs have fueled new approaches to affordability—this piece looks at how Cost Plus Drugs is challenging traditional pricing models through transparency and access.

From mental health to chronic disease, digital therapeutics are opening new paths to care—while introducing challenges around access, usability, and reimbursement.

Diabetes Awareness Month highlights the growing impact of diabetes and the need to address barriers in prevention, management, access, and equity.

Telehealth is evolving beyond its pandemic surge—reshaping care delivery through targeted use cases, new reimbursement models, and a growing multichannel approach.

Alzheimer’s research has been marked by setbacks and breakthroughs—this piece looks at where the field stands today and what recent advances could mean for the future of care.

Once sidelined, psychedelics are reentering medical research—raising new questions about their role in mental health treatment, regulation, and access.

A closer look at how patient-centered care is reshaping healthcare outcomes, provider well-being, and the role of technology in empowering patients.

Improving adoption of a digital CBT solution for IBS care by addressing access gaps, provider engagement, and patient acceptance through tailored strategy and resources.

Overcoming payer access challenges for a women’s health device with tailored strategy and value communication.

Addressing employer-channel communication challenges through tailored value messaging and coordinated materials.

Unlock global market access with insider strategies, real-world success stories, and future-shaping innovations.

Crack the code to US market access with key players, bold trends, and game-changing insights.

A real-world example of adapting a portfolio value strategy for emerging markets, with tailored engagement tools and training to support field teams and drive regional adoption.

How an immersive experience was developed to help NSM attendees better understand customer mindsets and scenarios through strategic persona-based and real-world scenarios.

Learn how a top 20 pharma company streamlined its payer value proposition into six clear messages and tools for tailored health system value storytelling.

Healthcare payment is shifting beyond fee-for-service, with alternative models reshaping how quality, efficiency, and outcomes are measured and rewarded.

A closer look at how tariffs and trade policy are influencing drug prices, supply chains, and access in today’s complex pharmaceutical landscape.

Insights from a Lunch & Learn discussion on employer health plans, focusing on transparency, fiduciary approaches, and smarter strategies to control costs and improve outcomes.

AI is moving healthcare beyond traditional limits, enhancing diagnostic processes, enabling tailored therapies, and accelerating discovery across the care continuum.

A closer look at how early planning, evidence generation, and payer alignment come together to create a durable market access strategy.

After launch, the real work begins. Post-market access monitoring helps ensure long-term success by tracking how therapies perform in the real world.